Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Balestro

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Frontiers in Medicine|September 27, 2021
Disease Severity and Prognosis of SARS-CoV-2 Infection in Hospitalized Patients Is Not Associated With Viral Load in Nasopharyngeal SwabElisabetta Cocconcelli, Gioele Castelli, Francesco Onelia, et al.
Frontiers in Immunology|July 4, 2025
Predicting biomarkers of progressive pulmonary fibrosis: morphological, cytokine profile, and clinical portraitNicol Bernardinello, Federica Pezzuto, Lauren D'Sa, et al.
Chest|July 17, 2012
Expression of the atypical chemokine receptor D6 in human alveolar macrophages in COPDErica Bazzan, Marina Saetta, Graziella Turato, et al.
American Journal of Respiratory and Critical Care Medicine|August 16, 2008
IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary diseaseFiorella Calabrese, Simonetta Baraldo, Erica Bazzan, et al.
Frontiers in Medicine|April 19, 2021
The Diagnostic Yield of the Multidisciplinary Discussion in Patients With COVID-19 PneumoniaFiorella Calabrese, Federica Pezzuto, Chiara Giraudo, et al.
Plos One|June 17, 2021
Reduced muscle mass as predictor of intensive care unit hospitalization in COVID-19 patientsChiara Giraudo, Giovanni Librizzi, Giulia Fichera, et al.
Scientific Reports|April 15, 2018
Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosisDavide Biondini, Elisabetta Balestro, Donato Lacedonia, et al.
Internal and Emergency Medicine|May 27, 2020
Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosisElisabetta Cocconcelli, Roberto Tonelli, Gianluca Abbati, et al.
Journal of Clinical Medicine|September 22, 2019
High-Resolution CT Change over Time in Patients with Idiopathic Pulmonary Fibrosis on Antifibrotic TreatmentElisabetta Balestro, Elisabetta Cocconcelli, Chiara Giraudo, et al.
American Journal of Respiratory and Critical Care Medicine|November 21, 2014
Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigmSimonetta Baraldo, Graziella Turato, Francesca Lunardi, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Frontiers in Medicine|September 27, 2021
Disease Severity and Prognosis of SARS-CoV-2 Infection in Hospitalized Patients Is Not Associated With Viral Load in Nasopharyngeal SwabElisabetta Cocconcelli, Gioele Castelli, Francesco Onelia, et al.
Frontiers in Immunology|July 4, 2025
Predicting biomarkers of progressive pulmonary fibrosis: morphological, cytokine profile, and clinical portraitNicol Bernardinello, Federica Pezzuto, Lauren D'Sa, et al.
Chest|July 17, 2012
Expression of the atypical chemokine receptor D6 in human alveolar macrophages in COPDErica Bazzan, Marina Saetta, Graziella Turato, et al.
American Journal of Respiratory and Critical Care Medicine|August 16, 2008
IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary diseaseFiorella Calabrese, Simonetta Baraldo, Erica Bazzan, et al.
Frontiers in Medicine|April 19, 2021
The Diagnostic Yield of the Multidisciplinary Discussion in Patients With COVID-19 PneumoniaFiorella Calabrese, Federica Pezzuto, Chiara Giraudo, et al.
Plos One|June 17, 2021
Reduced muscle mass as predictor of intensive care unit hospitalization in COVID-19 patientsChiara Giraudo, Giovanni Librizzi, Giulia Fichera, et al.
Scientific Reports|April 15, 2018
Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosisDavide Biondini, Elisabetta Balestro, Donato Lacedonia, et al.
Internal and Emergency Medicine|May 27, 2020
Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosisElisabetta Cocconcelli, Roberto Tonelli, Gianluca Abbati, et al.
Journal of Clinical Medicine|September 22, 2019
High-Resolution CT Change over Time in Patients with Idiopathic Pulmonary Fibrosis on Antifibrotic TreatmentElisabetta Balestro, Elisabetta Cocconcelli, Chiara Giraudo, et al.
American Journal of Respiratory and Critical Care Medicine|November 21, 2014
Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigmSimonetta Baraldo, Graziella Turato, Francesca Lunardi, et al.
Pageof 10